Latest Glutathione Stories
BEVERLY HILLS, Calif., Nov.
PALO ALTO, Calif., Oct. 26 /PRNewswire/ -- Telik, Inc.
SAN DIEGO, Sept. 2 /PRNewswire/ -- LifeVantage Corporation (OTC Bulletin Board: LFVN), the maker of ProtandimÂ®, a clinically proven, science-based therapy for oxidative stress, announced today that a new peer-reviewed study involving ProtandimÂ® was published in the scientific journal PLoS ONE.
BEVERLY HILLS, Calif., Aug. 26 /PRNewswire-FirstCall/ -- OXIS INTERNATIONAL, INC.
PALO ALTO, Calif., July 12 /PRNewswire-FirstCall/ -- Telik, Inc.
SAN DIEGO, June 22 /PRNewswire-FirstCall/ -- LifeVantage Corporation (OTC Bulletin Board: LFVN), the maker of ProtandimÂ®, a patented, science-based solution to oxidative stress, announced today that a peer-reviewed manuscript was published in the Journal of Dietary Supplements examining the beneficial effects of ProtandimÂ® on a mouse model of Duchenne Muscular Dystrophy (DMD), an X-linked inherited disease affecting one in 3,500 males.
PALO ALTO, Calif., June 21 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdaq: TELK) today announced the publication of a case report by Quddus et al., Oral Ezatiostat HCl (Telintra) and Myelodysplastic Syndrome: A case report of sustained hematologic response following an abbreviated exposure.
Researchers at the Tulane University School of Medicine, in New Orleans, LA, have demonstrated that thymoquinone (TQ) a major component of black seed oil (Nigella sativa) can suppress the growth of several aggressive prostate cancer (PCa) cell lines, in vitro.
PALO ALTO, Calif., April 22 /PRNewswire-FirstCall/ -- Telik, Inc.
First study to demonstrate association between asthma and acetaminophen is linked to gene involved in detoxification of foreign substances.